期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 233, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2022.114227
关键词
SUMO; Inhibitor; SENP; Cancer; Post-translationalmodification
资金
- National Natural Science Foundation of China [21877128]
- Double First-Class University Project [CPU2018GY03]
SUMOylation is a key post-translational modification process that is essential for normal cellular functions. Dysregulation of SUMOylation is associated with various diseases, and small-molecular inhibitors targeting this pathway have been discovered.
SUMOylation is a key post-translational modification that involves the covalent attachment of small ubiquitin-like modifier (SUMO) to the lysine residues of target proteins. The well-balanced SUMOylation is essential for normal cellular behaviors, while disturbance of SUMOylation is associated with various cancers and other diseases. Herein, we summarize the structures and biological functions of proteins involved in the SUMOylation process, their dysregulation in human diseases, and the discovery of small-molecular inhibitors targeting this pathway. In addition, we highlight the emerging trends in this field.(c) 2022 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据